- Home
- CNSP vs YMAT Comparison
CNSP vs YMAT Comparison
Compare CNSP & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNSP | YMAT |
|---|---|---|
| Founded | 2017 | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.3M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNSP | YMAT |
|---|---|---|
| Price | $5.84 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 7.9K | ★ 822.6K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.24 |
| 52 Week High | $10.59 | $2.94 |
Technical Indicators
Market Signals| Indicator | CNSP | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 56.02 |
| Support Level | $4.63 | $0.33 |
| Resistance Level | $6.07 | $2.19 |
| Average True Range (ATR) | 0.29 | 0.26 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 41.34 | 82.55 |
Price Performance
Historical ComparisonAbout CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.